ASX Filings

Opthea Phase 2b wAMD trial fully recruited ahead of schedule

November 14, 2018

Appendix 3B

November 12, 2018

Appendix 3B

November 9, 2018

Change in substantial holding

November 9, 2018

Appendix 3B

November 2, 2018

Opthea Receives A$12m R&D Tax Incentive

October 31, 2018

Letter to Option Holders

October 30, 2018

Notice of Annual General Meeting and Proxy Form

October 29, 2018

Opthea Provides Update on Key Opinion Leader Forum

October 29, 2018

Opthea CEO Presentation of Trial Updates at OIS@AAO 2018

October 26, 2018